Previous Terms of Clearance continue: Prior to the renewal of the 0920-1282 umbrella generic, CDC will consult with the desk officer to develop a plan for the restructuring of existing instruments, which span multiple programs. Moving forward, OMB will not approve multi-program instruments through this generic unless otherwise agreed upon prior to submission. Gen ICs that are methodologically complex, that could benefit from public comment, or that could otherwise necessitate more in-depth review may need to be resubmitted as new ICRs. GenICs under this generic are approved so long as the umbrella generic is active; for GenICs requiring data collection beyond a three-year approval, CDC will need to renew the umbrella generic. Revisions to GenICs should be submitted as change requests. CDC should complete an update to the Completion and Carryover Summary document with each GenIC submission and/or renewal of the umbrella generic. For programs requesting a change in data collection frequency (other than annual), CDC will note this in the GenIC Request Template and provide justification.
Approved consistent with the understanding that CDC will submit individual collections under this generic clearance to OMB. These submissions will include the actual study instruments along with a completed template describing the performance metrics used. Approved consistent with the understanding that the agency will use this generic specifically for program improvement and accountability associated with cooperative agreements and grants. CDC will send OMB an annual report summarizing the number of hours used, as well as the nature and results of the activities completed under this clearance.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
06/30/2026
06/30/2026
06/30/2026
11,826
0
11,826
291,147
0
291,147
0
0
0
The purpose of this generic data collection is to: 1) help CDC programs and their recipients develop strong performance measurement systems and practices; 2) define and operationalize priority performance measures; and 3) establish common data collection and reporting expectations. Data will enable the accurate, reliable, uniform and timely submission of recipients' progress. This Non-Substantive Change Request is submitted to incorporate two additional collections in the TEP template to respectively monitor progress and completion of the TEPs through 2024 and 2025. These two collections are found in Appendix A, sections 2 and 3. The total change in burden over 2 cycles of data collection (2024 and 2025) is 214 hours (107 additional hours of annualized burden). These Change Requests are submitted to meet 0920-1282 Generic mechanism Terms of Clearance.
CDC requests an increase in burden and responses to accommodate expanded eligibility criteria for participation in the PMP and anticipated increase in usage of this generic by CDC/ATSDR programs. In addition, many programs are funded for multiple years and will need to collect performance data for the entire period of performance.
Note that the change in the total cost burden appears to be very large. However, the change in total cost burden is associated with the change in accounting method. In the past, CDC reported the cost burden for each IC as the wage-equivalents that appear in Section 12.B of the supporting statement. Consistent with the rest of HHS, CDC is now reporting the total from Section 13 in the "burden cost" field for each IC. Section 13 covers nonwage costs (e.g., equipment). As such, costs associated with these ICs are now "zero."
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
[OADPS] [PMP] A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.